S3 guideline complementary medicine in the treatment of oncological patients


The S3 Guideline for Complementary Medicine in the Treatment of Oncological Patients issued by the Working Group of the German Scientific Medical Societies (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V.) of the German Cancer Society (Deutsche Krebsgesellschaft) and the German Cancer Aid (Deutsche Krebshilfe) is completed since September 2021. It shows that the subcutaneous administration of mistletoe extracts (Viscum album L.) can be used to improve quality of life in patients with solid tumours (evidence level 1a).


Last update: November 24th, 2021/AT1

Go to Heaven